EMILY FISHEL: Open Payments
NPI 1083149090 · GREENWOOD, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$405 in 20 payments from 12 companies in 2025. Trend: 2023 $226 · 2024 $72 · 2025 $405
Food & beverage: $405
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $93 |
| PFIZER INC. | 4 | $82 |
| Astellas Pharma US Inc | 2 | $54 |
| Exact Sciences Corporation | 2 | $29 |
| Vanda Pharmaceuticals Inc. | 1 | $27 |
| ABBVIE INC. | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Novo Nordisk Inc | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Amgen Inc. | 1 | $15 |
Products named: REXULTI, NURTEC ODT, Veozah, The Cologuard Plus Collection Kit, FANAPT, BOTOX, Auvelity, Ozempic.
Industry payments across IN — which companies pay providers there.
